Effects of tranexamic acid and aprotinin, two antifibrinolytic drugs, on PAF-induced plasma extravasation in unanesthetized rats

Inflammation

Volumn 24, Issue 5, 2000, Pages 411-429

  O'Brien, Jeannick G ^a   Battistini, Bruno ^a   Zaharia, FrançCoise ^a   Plante, Gérard E ^a   Sirois, Pierre ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIFIBRINOLYTIC AGENT; APROTININ; THROMBOCYTE ACTIVATING FACTOR; TRANEXAMIC ACID;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CAPILLARY LEAK SYNDROME; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DRUG EFFECT; EDEMA; EXTRAVASATION; MALE; MICROCIRCULATION; NONHUMAN; POSTOPERATIVE HEMORRHAGE; RAT;

ANIMALS; ANTIFIBRINOLYTIC AGENTS; AORTA; APROTININ; BRONCHI; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; COLORING AGENTS; DUODENUM; EVANS BLUE; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; MALE; MICROCIRCULATION; ORGAN SPECIFICITY; PANCREAS; PLATELET ACTIVATING FACTOR; POSTOPERATIVE COMPLICATIONS; PULMONARY CIRCULATION; RATS; RATS, WISTAR; TIME FACTORS; TRANEXAMIC ACID;

ANIMALIA;

EID: 0344195526     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007060011553     Document Type: Article

References (40)

1. 1. KIRKLIN, J. K., E. H. BLACKSTONE, and J. W. KIRKLIN. 1987. Cardiopulmonary bypass: Studies on its damaging effects. Blood Purific. 5:168-178.
2. 2. WACHTFOGEL, Y. T., U. KUCICH, J. GREENPLATE, P. GLUSZKO, W. ABRAMS, G. WEINBAUM, R. K. WENGER, B. RUCINSKI, S. NIEWIAROWSKI, and L. H. EDMUNDS. 1987. Human neutrophil degranulation during extracorporeal circulation. Blood 69:324-330.
3. 3. EDMUNDS, L. H. JR, N. ELLISON, R. W. COLMAN, S. NIEWIAROWSKI, A. K. RAO, V. P. ADDONIZIO, L. W. STEPHENSON, and R. N. EDIE. 1982. Platelet function during cardiac operation: Comparison of membrane and bubble oxygenators. J. Thorac. Candiovasc. Surg. 83:805-812.
4. 4. MOFFIT, E. A., J. W. KIRKLIN, and R. A. THEYE. 1962. Physiologic studies during whole-body perfusion in tetralogy of Fallot. J. Thorac. Cardiovasc. Surg. 44:180-188.
5. 5. PAGE, C. P., C. B. ARCHER, W. PAUL, and J. MORLEY. 1990. PAF-aceter: a mediator of inflammation and asthma. Trends Pharmacol. Sci. 5:239-241.
6. 6. RUBIN, A. H. E., L. J. SMITH, and R. PATTERSON. 1987. The bronchoconstrictor properties of platelet activating factors in humans. Am. Rev. Respir. Dis. 136:1145.
7. 7. WIRTZ, H., M. LANG, U. SANNWALD, and H. HAHN. 1986. Mechanism of platelet activating factor (PAF) induced secretion of mucus from tracheal submucosal glands in ferret. Fed. Proc. 45:418-421.
8. 8. WARDLAW, A. J., R. MOQBEL, O. CROMWELL, and A. B. KAY. 1986. Platelet-activating factor: a potent chemotactic and chemokinetic factor for human eosinophils. J. Clin. Invest. 78:1701.
9. 9. CUSS, F. M., C. M. S. DIXON, and P. J. BARNES. 1986. Effects of inhaled platelet-activating factor on pulmonary function and bronchial hyperesponsiveness in man. Lancet 2:189-192.
10. 10. ARCHER, C. B., C. P. PAGE, W. PAUL, J. MORLEY, and D. A. MCDONALD. 1984. Inflammatory characteristics of platelet activating factor (PAF-aceter) in human skin. Br. J. Dermatol. 110:45-50.
11. 11. SIROIS, M. G., G. E. PLANTE, P. BRAQUET, and P. SIROIS. 1990. Role of eicosanoids in PAF-induced increases of the vascular permeability in rat airways. Br. J. Pharmacol. 101:896-900.
12. 12. GOLDENGERG, M. M., and R. D. MEURER. 1984. A pharmacologic analysis of the action of platelet-activating factor in the induction of hind-paw oedema in the rat. Prostaglandins 28:271-278.
13. 13. HARDY, J. F., and S. BELISLE. 1994. Natural and synthetic antifibrinolytics in adult cardiac surgery: Efficacy and effectiveness. Can. J. Anaesth. 41:1104-1112.
14. 14. PUGH, S. C., and A. K. WIELOGORSKI. 1995. A comparison of the effects of tranexamic acid and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing cardiac surgery. J. Cardiothor. Vasc. Anes. 9:240-244.
15. 15. TRAUTSCHOLD, I., E. WERLE, and G. ZICKGRAF-RUEDEL. 1966. The kallikrein-trypsin inhibitor. Arzeim Forsch 16:1507-1515.
16. 16. ASTEDT, B. Clinical pharmacology of tranexamic acid. 1987. Scand. J. Gastroenterol. 137:225.
17. 17. SIROIS, M. G., S. JANCAR, P. BRAQUET, G. E. PLANTE, and P. SIROIS. 1988. PAF increases vascular permeability in selected tissues: Effect of BN-52021 and L-655,240. Prostaglandins 36:631-644.
18. 18. ROGERS, D. F., P. BOSCHETTO, and P. J. BARNES. 1989. Plasma exudation correlation between Evans blue dye and radiolabeled albumin in guinea-pig airways in vivo. J. Pharmacol. Meth. 21:309-315.
19. 19. PATTERSON, C. E., R. A. RHOADES, and J. G. N. GARCIA. 1992. Evans blue as a marker of albumin clearance in cultured endothelial monolayer and isolated lung. J. Appl. Physiol. 72:865-873.
20. 20. MOVAT, H. Z., and N. L. DILORENZO. 1968. Activation of plasma kinin system by antigen-anti-body aggregates. I. Generation of permeability factor in guinea-pig serum. Lab. Invest. 19:187.
21. 21. UDAKA, K., Y. TAKEUCHI, and H. Z. MOVAT. 1970. Simple method for quantitation of enhanced vascular permeability. Proc. Soc. Exp. Biol. Med. 133:1384.
22. 22. FRIMMER, M., and F. W. MULLER. 1962. Branchbarkeit und grenzen der forbstoffmethoden zur bestimmung vermehrter durchlassigkeitder haut-capillaren. Med. Exp. 6:327-330.
23. 23. EVANS, T. W., K. F. CHUNG, D. F. ROGERS, and P. J. BARNES. 1987. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. J. Appl. Physiol. 63:479-484.
24. 24. SIROIS, M. G., W. T. DE LIMA, A. J. DE BRUM FERNANDES, R. J. JOHNSON, G. E. PLANTE, and P. SIROIS. 1994. Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes. Br. J. Pharmacol. 111:1111-1116.
25. 25. O'DONNELL, S. R., and J. K. BARNETT. 1987. Microvascular leakage to platelet-activating factor in guinea-pig trachea and bronchi. Eur. J. Pharmacol. 138:385-396.
26. 26. O'BRIEN, J. G., B. BATTISTINI, R. J. JOHNSON, F. ZAHARIA, G. E. PLANTE, and P. SIROIS. 1997. Participation of neutrophils or platelets in the effect of tranexamic acid or aprotinin against bradykinin induced plasma extravasation in conscious rats. Can. J. Physiol. Pharmacol. 75:741-749.
27. 27. VIOSSAT, I., J. M. GUILLON, E. ETIEMBE, and E. PIROTZKY. 1988. Use of ginkolides on PAF-acether induced hypotension and cardiac modifications. In: Braquet, P, editor. Ginkolides: Chemistry, Biology, Pharmacology and Clinical Perspectives. New York; 365-375.
28. 28. YASUDA, K., M. TAKASHIMA, and I. SAWARAGI. 1995. Influence of cigarette smoke extract on the hormonal regulation of PAF acethylhydrolase in rats. Biol. Reprod. 53:244-252.
29. 29. THOMAS, T. K., R. S. CHESONIS, D. SCHMOLZE, J. SYMINGTON, M. L. HARBISON, A. WALSER, and P. C. WILL. 1993. Differential antagonism of PAF-induced neutrophilia and gastric hemorrhage in the rat. Agents & Actions 39:C195-C197.
30. 30. REGOLI, D., and J. BARABE. Pharmacology of bradykinin and related kinins. 1980. Pharmacol. Rev. 32:1-46.
31. 31. HOSHIKAWA-FUJIMURA, A. Y., J. O. AULER, T. R. DA ROCHA, L. I. BRANDIZZI, J. M. PASCUAL, D. A. CHAMONE, and A. D. JATENE. 1989. PAF-aceter, superoxide anion andy β-glucuronidase as parameters of polymorphonuclear cell activation associated with cardiac surgery and cardiopulmonary bypass. Braz. J. Med. Biol. Res. 22:1077-1182.
32. 32. RUVOLO, G., G. SPEZIALE, E. GRECO, L. TRITAPEPE, V. MOLLACE, G. NISTICO, and B. MARINO. 1995. Nitric oxide release during hypothermic versus normothermic cardiopulmonary bypass. Eur. J. Cardio. Thor. Surg. 9:651-654.
33. 33. EZEAMUZI, J. C., and A. C. NJOKU. 1992. The role of neutrophils in acute and chronic inflammation in rats. Afr. J. Med. Med. Sci. 21:23-28.
34. 34. TEPPERMAN, B. L., B. L. VOZZOLO, and B. D. SOPER. 1993. Effect of neutropenia on gastric mucosal integrity and mucosal nitric oxide synthesis in the rat. Dig. Dis. Sci. 38:2056-2061.
35. 35. POJDA, S. M., and J. R. VANE. 1971. Inhibitory effects of aprotinin on kallikrein and kininases in dog's blood. Br. J. Pharmacol. 42:558-568.
36. 36. MURKIN, J. M. 1994. Tranexamic acid is not better than aprotinin in decreasing bleeding after cardiac surgery. J. Cardiothor. Vasc. Anes 8:474-476.
37. 37. CORBEAU, J. J., J. P. MONRIGAL, J. P. JACOB, C. COTTINEAU, X. MOREAU, J. G. BUKOWSKI, J. B. SUBAYI, and A. DELHUMEAU. 1995. Comparison of effects aprotinin and tranexamic acid on blood loss in heart surgery. Ann. Fran. Anesth. Reanim. 14:154-161.
38. 38. BOUGHENOU, F., S. MADI-JEBARA, S. MASSONNET-CASTEL, L. BENMOSBAH, A. CARPENTIER, and M. T. COUSIN. 1995. Fibrinolytic inhibitors and prevention of bleeding in cardiac valve surgery. Comparison of tranexamic acid and high dose aprotinin. Arch. Mal. Coeur Vais. 88:363-370.
39. 39. GUENTHER, C. R. 1994. Tranexamic acid is better than aprotinin in decreasing bleeding after cardiac surgery. J. Cardiothor. Vasc. Anes. 8:471-473.
40. 40. ZEHR, K. J., R. S. POSTON, P. C. LEE, K. UTHOFF, P. KUMAR, P. W. CHO, A. M. GILLINOV, J. M. REDMOND, J. A. WINKELSTEIN, and A. HERSKOWITZ. 1995. PAF inhibition reduces lung injury after CPB. Annals Thor. Med. 59:328-335.